ProBioGen delivers strong 2022 performance
ProBioGen was able to carry on its rapid growth trajectory by completing a significantly increased number of projects.
ProBioGen was able to carry on its rapid growth trajectory by completing a significantly increased number of projects.
This expansion follows the groundbreaking of a large-scale commercial drug product facility in Stein (CH), in another milestone for Lonza’s Drug Product Services (DPS) offering
Pre-filled pens containing a combination of insulin glargine 100 Units/mL and lixisenatide for once-daily dosing
FedEx will be displaying a wide-range of effective healthcare packaging and specialized tracking technology
Rocuronium Bromide Injection had an annual sale of approximately US $53 million in the US (IQVIA MAT December 2022)
Various healthcare companies are already implementing high-tech solutions into existing healthcare systems.
Kyndryl's multi-cloud management solution leverages AI-based, cloud-hosted models to provide real-time metrics, events, logs, and traces
This new capability represents a significant shift from a microscope-based standard of care to the use of digital whole slide images
New GMP facility for clinical and small-scale commercial pharmaceutical lipids
Subscribe To Our Newsletter & Stay Updated